Mike Fillon
Impact in
-
- Smoking Behavior and Cessation
-
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
- Oncology 12
- Cancer Risks and Factors 4
- Global Cancer Incidence and Screening 4
- COVID-19 and healthcare impacts 2
- Cutaneous Melanoma Detection and Management 1
-
- Smoking Behavior and Cessation 3
In The Last Decade
Mike Fillon
28 papers receiving 112 citations
Peers
Comparison fields: 5 of 56
- Physiology 27
- Cancer Research 15
- Oncology 23
- Health Informatics 1
- Health, Toxicology and Mutagenesis 8
Countries citing papers authored by Mike Fillon
This map shows the geographic impact of Mike Fillon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Fillon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Fillon more than expected).
Fields of papers citing papers by Mike Fillon
This network shows the impact of papers produced by Mike Fillon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Fillon. The network helps show where Mike Fillon may publish in the future.
No co-authors to show.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 25 | |
| 2 | 2015 | 13 | |
| 3 | 2015 | 7 | |
| 4 | 2022 | 7 | |
| 5 | 2021 | 6 | |
| 6 | 2012 | 6 | |
| 7 | 2013 | 5 | |
| 8 | 2011 | 5 | |
| 9 | 2017 | 4 | |
| 10 | 2013 | 4 | |
| 11 | 2016 | 3 | |
| 12 | 2012 | 3 | |
| 13 | 2022 | 3 | |
| 14 | 2014 | 3 | |
| 15 | 2012 | 3 | |
| 16 | 2017 | 2 | |
| 17 | 2016 | 2 | |
| 18 | 2014 | 2 | |
| 19 | 2016 | 2 | |
| 20 | 2016 | 2 |
About Mike Fillon
Mike Fillon is a scholar working on Oncology, Physiology, Cancer Research, Economics and Econometrics and Molecular Biology, having authored 34 papers that have together received 115 indexed citations. Recurring topics across this work include Cancer Risks and Factors (4 papers), Global Cancer Incidence and Screening (4 papers), Smoking Behavior and Cessation (3 papers), Cancer Genomics and Diagnostics (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Economic and Financial Impacts of Cancer (2 papers), COVID-19 and healthcare impacts (2 papers) and Cutaneous Melanoma Detection and Management (1 paper). The work is most often cited by research in Physiology (27 citations), Cancer Research (15 citations), Oncology (23 citations), Health Informatics (1 citation) and Health, Toxicology and Mutagenesis (8 citations). Their work appears in journals such as JNCI Journal of the National Cancer Institute and CA A Cancer Journal for Clinicians.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.